S.C. Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$431K Buy
5,987
+539
+10% +$40.6K 0.66% 49
2022
Q3
$387K Buy
5,448
+281
+5% +$20.4K 0.61% 55
2022
Q2
$398K Buy
5,167
+48
+0.9% +$3.66K 0.61% 55
2022
Q1
$374K Buy
5,119
+42
+0.8% +$2.82K 0.48% 71
2021
Q4
$328K Buy
+5,077
New +$298K 0.38% 87

Other funds holding BMY

S.C. Financial Services's BMY Position: Q4 2022 in Review

S.C. Financial Services increased its Bristol-Myers Squibb (BMY) stake by 9.9% in Q4 2022, buying an estimated $40.6K and bringing the position to 5,987 shares worth $431K. The position accounts for 0.66% of the portfolio, ranked #49.

S.C. Financial Services first reported a position in BMY in Q4 2021 and has held it in 5 quarters since. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • S.C. Financial Services held 5,987 shares of Bristol-Myers Squibb worth $431K as of Q4 2022.
  • S.C. Financial Services bought 539 Bristol-Myers Squibb shares in Q4 2022, an estimated $40.6K.
  • Bristol-Myers Squibb made up 0.66% of S.C. Financial Services's portfolio in Q4 2022, its #49 holding.
  • S.C. Financial Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 5 quarters since.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on S.C. Financial Services's 13F filing for Q4 2022, filed 20 Jan 2023.